In high-grade serous ovarian cancer (HG-SOC), the most common subtype, BRCA1/2 germline and somatic mutations are frequent (17-25%), with somatic mutations representing 18-30% of all BRCA1/2 mutations [8, 9]. Here, BRCA1 is linked to ovarian serous adenocarcinoma.